Filed: 11/10/2025ACC: 0001193125-25-274459
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $212.45M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$212.45M
Total AUM (reported)
15.96M
Total Shares
Allocation by class
COMMON STOCK$202.81M95.5%
COMMON SHARES$9.65M4.5%
Portfolio Concentration
Top 3$178.81M84.2%
4–10$33.64M15.8%
Top 3 weight
84.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 15.96M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
15.96M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other9
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings9
Rows:
Lenz Therapeutics, Inc.
OTRShares2.66M
TypeSH
Market value$123.76M
58.25%
Sole
0.00
Shared
2.66M
None
0.00
Monte Rosa Therapeutics, Inc.
OTRShares5.65M
TypeSH
Market value$41.89M
19.72%
Sole
0.00
Shared
5.65M
None
0.00
Jade Biosciences, Inc.
OTRShares1.53M
TypeSH
Market value$13.17M
6.20%
Sole
0.00
Shared
1.53M
None
0.00
CRISPR Therapeutics AG
OTRShares148.83K
TypeSH
Market value$9.65M
4.54%
Sole
0.00
Shared
148.83K
None
0.00
Skye Bioscience, Inc.
OTRShares2.01M
TypeSH
Market value$7.89M
3.71%
Sole
0.00
Shared
2.01M
None
0.00
Contineum Therapeutics, Inc.
OTRShares542.63K
TypeSH
Market value$6.38M
3.00%
Sole
0.00
Shared
542.63K
None
0.00
Repare Therapeutics, Inc.
OTRShares2.65M
TypeSH
Market value$4.66M
2.19%
Sole
0.00
Shared
2.65M
None
0.00
Tempest Therapeutics, Inc.
OTRShares269.77K
TypeSH
Market value$2.77M
1.31%
Sole
0.00
Shared
269.77K
None
0.00
Adverum Biotechnologies, Inc.
OTRShares506.82K
TypeSH
Market value$2.30M
1.08%
Sole
0.00
Shared
506.82K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Lenz Therapeutics, Inc.OTR | Common Stock | 2.66M | SH | $123.76M 58.25% | 0.00 | 2.66M | 0.00 |
Monte Rosa Therapeutics, Inc.OTR | Common Stock | 5.65M | SH | $41.89M 19.72% | 0.00 | 5.65M | 0.00 |
Jade Biosciences, Inc.OTR | Common Stock | 1.53M | SH | $13.17M 6.20% | 0.00 | 1.53M | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 148.83K | SH | $9.65M 4.54% | 0.00 | 148.83K | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $7.89M 3.71% | 0.00 | 2.01M | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 542.63K | SH | $6.38M 3.00% | 0.00 | 542.63K | 0.00 |
Repare Therapeutics, Inc.OTR | Common Stock | 2.65M | SH | $4.66M 2.19% | 0.00 | 2.65M | 0.00 |
Tempest Therapeutics, Inc.OTR | Common Stock | 269.77K | SH | $2.77M 1.31% | 0.00 | 269.77K | 0.00 |
Adverum Biotechnologies, Inc.OTR | Common Stock | 506.82K | SH | $2.30M 1.08% | 0.00 | 506.82K | 0.00 |